Insider Purchase: Chief Executive Officer of Cemteme Corp. (CNC) Buys 4,117 Shares
Insider Purchase: Chief Executive Officer of Cemteme Corp. (CNC) Buys 4,117 Shares
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.SARAH LONDON, the Chief Executive Officer of Cemteme Corp. ($CNC), bought 4,117 shares of the company on 11-08-2024. We received data on the trade from a recent SEC filing. This increased their holdings by approximately 0.6%. Following this trade, they now own 667,229 shares of Cemteme Corp. stock.
Cemteme Corp.（$CNC）的首席执行官SARAH LONDON于2024年11月8日购买了4,117股该公司的股票。我们从最近的SEC备案中获得了这笔交易的数据。这次交易使他们的持股大约增加了0.6％。在这笔交易之后，他们现在拥有667,229股Cemteme Corp.股票。
Cemteme Corp. Insider Trading Activity
Cemteme Corp.内部交易活动
Cemteme Corp. insiders have traded $CNC stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Cemteme Corp.内部人士在过去6个月中已经在公开市场上3次交易了$CNC股票。其中1次是买入，2次是卖出。
Here's a breakdown of recent trading of $CNC stock by insiders over the last 6 months:
以下是Cemteme Corp.内部人士在过去6个月内对$CNC股票的最新交易情况的详细信息：
- SARAH LONDON (Chief Executive Officer) purchased 4,117 shares.
- CHRISTOPHER J COUGHLIN sold 878 shares.
- KENNETH J FASOLA (President) sold 8,000 shares.
- SARAH LONDON（首席执行官）购买了4,117股。
- CHRISTOPHER J COUGHLIN卖出了878股。
- KENNETH J FASOLA（总裁）卖出了8,000股。
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
要跟踪内部交易，请查看Quiver Quantitative的内部交易特斯拉-仪表。
Cemteme Corp. Hedge Fund Activity
Cemteme公司-对冲基金活动
We have seen 413 institutional investors add shares of Cemteme Corp. stock to their portfolio, and 475 decrease their positions in their most recent quarter.
我们看到有413家机构投资者在他们的投资组合中增加了Cemteme公司股票的持股，而475家在他们最近的一个季度减少了他们的持仓。
Here are some of the largest recent moves:
以下是一些最近最大的交易动态：
- HARRIS ASSOCIATES L P added 7,900,876 shares (+46.5%) to their portfolio in Q2 2024
- BLACKROCK INC. added 5,155,823 shares (+12.2%) to their portfolio in Q2 2024
- FMR LLC removed 4,890,272 shares (-12.2%) from their portfolio in Q2 2024
- SWEDBANK AB removed 4,732,516 shares (-46.7%) from their portfolio in Q3 2024
- NORGES BANK added 3,351,653 shares (+18.8%) to their portfolio in Q2 2024
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,778,827 shares (-51.0%) from their portfolio in Q2 2024
- CARMIGNAC GESTION added 2,246,028 shares (+inf%) to their portfolio in Q2 2024
- HARRIS ASSOCIATES L P在2024年第二季度将7,900,876股（+46.5%）加入其投资组合
- BLACKROCk INC.在2024年第二季度将5,155,823股（+12.2%）加入他们的投资组合
- FMR LLC在2024年第二季度从其投资组合中剔除了4,890,272股（-12.2%）
- SWEDBANk Ab在2024年第三季度从其投资组合中剔除了4,732,516股（-46.7%）
- NORGES BANk在2024年第二季度将3,351,653股（+18.8%）加入了他们的投资组合
- PRICE t ROWE ASSOCIATES INC /MD/在2024年第二季度从其投资组合中减持了2,778,827股股票（-51.0%）
- CARMIGNAC GESTION在2024年第二季度向其投资组合中增加了2,246,028股股票（+inf%）
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
要追踪对冲基金的股票组合，请查看Quiver Quantitative的机构持股仪表板。
Cemteme Corp. Congressional Stock Trading
Cemteme corp. 国会股票交易
Members of Congress have traded $CNC stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
国会议员在过去6个月内交易了$CNC股票2次。这些交易中，2次是买入，0次是卖出。
Here's a breakdown of recent trading of $CNC stock by members of Congress over the last 6 months:
以下是国会议员在过去6个月内对$CNC股票的最新交易情况:
- REPRESENTATIVE KATHY E. MANNING has traded it 2 times. They made 2 purchases worth up to $30,000 on 07/02 and 0 sales.
- 代表KATHY E. MANNING已进行了2次交易。他们于07/02进行了2笔买入交易，总价值高达$30,000，没有卖出。
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
要追踪国会股票交易，请查看Quiver Quantitative的国会交易仪表板。
Should I Buy $CNC Stock?
Should I Buy $CNC Stock?
For Centene Corporation ($CNC), the bull case centers around its promising financial outlook, particularly within its Pharmacy Division, which is projected to see significant revenue growth driven by a $100 year-over-year increase in direct subsidies expected in 2025. This growth, coupled with the company's robust presence in the Medicaid sector and its strategic positioning in key managed care states, positions Centene favorably for expansion in the Health Insurance Marketplace as subsidies are likely to be renewed post-2025. Additionally, strong management efforts have led to positive adjustments in 2024 adjusted EPS estimates, improvements in Star ratings, and signs of returning Medicaid membership growth as operational challenges diminish. Conversely, the bear case emphasizes the significant membership losses Centene has faced due to declining continuous coverage and anticipated redetermination-driven losses that are expected to continue affecting revenues through the first half of 2025. Increased competition in the Medicaid market and pressured margins in both commercial and Medicaid sectors further raise concerns about the sustainability of revenue and earnings growth, leading to uncertainty about the company's long-term prospects.
For Centene Corporation ($CNC), the bull case centers around its promising financial outlook, particularly within its Pharmacy Division, which is projected to see significant revenue growth driven by a $100 year-over-year increase in direct subsidies expected in 2025. This growth, coupled with the company's robust presence in the Medicaid sector and its strategic positioning in key managed care states, positions Centene favorably for expansion in the Health Insurance Marketplace as subsidies are likely to be renewed post-2025. Additionally, strong management efforts have led to positive adjustments in 2024 adjusted EPS estimates, improvements in Star ratings, and signs of returning Medicaid membership growth as operational challenges diminish. Conversely, the bear case emphasizes the significant membership losses Centene has faced due to declining continuous coverage and anticipated redetermination-driven losses that are expected to continue affecting revenues through the first half of 2025. Increased competition in the Medicaid market and pressured margins in both commercial and Medicaid sectors further raise concerns about the sustainability of revenue and earnings growth, leading to uncertainty about the company's long-term prospects.
Background on $CNC Stock
Background on $CNC Stock
Cemteme Corp. (CNC) is a company focused on providing innovative solutions within the industrial and technical sectors, particularly in the areas of CNC (computer numerical control) machining and manufacturing. The company specializes in delivering precision-engineered components and systems, employing advanced manufacturing technologies to meet the needs of various industries such as aerospace, automotive, and electronics. Cemteme Corp. emphasizes efficiency, quality, and sustainability in its production processes, utilizing state-of-the-art machinery and cutting-edge software to optimize performance and ensure high standards. Through its commitment to innovation and customer service, CNC aims to be a leading player in the CNC machining industry, helping businesses enhance their operational capabilities and competitiveness.
Cemteme Corp. (CNC) is a company focused on providing innovative solutions within the industrial and technical sectors, particularly in the areas of CNC (computer numerical control) machining and manufacturing. The company specializes in delivering precision-engineered components and systems, employing advanced manufacturing technologies to meet the needs of various industries such as aerospace, automotive, and electronics. Cemteme Corp. emphasizes efficiency, quality, and sustainability in its production processes, utilizing state-of-the-art machinery and cutting-edge software to optimize performance and ensure high standards. Through its commitment to innovation and customer service, CNC aims to be a leading player in the CNC machining industry, helping businesses enhance their operational capabilities and competitiveness.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
本文不构成金融建议。有关Quiver Quantitative的免责声明，请查看更多信息。
